{"paper_id": "c8d3d45e25a50ec507a9d03ed104a8abe5e53ef0", "metadata": {"title": "Supporting Information Potent and Selective Inhibition of Cysteine Proteases from Plasmodium falciparum and Trypanosoma brucei", "authors": [{"first": "Veronika", "middle": [], "last": "Ehmke", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Cornelia", "middle": [], "last": "Heindl", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Matthias", "middle": [], "last": "Rottmann", "suffix": "", "affiliation": {}, "email": ""}, {"first": "C\u00f8line", "middle": [], "last": "Freymond", "suffix": "", "affiliation": {}, "email": ""}, {"first": "]", "middle": ["W Bernd"], "last": "Schweizer", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Reto", "middle": [], "last": "Brun", "suffix": "", "affiliation": {}, "email": ""}, {"first": "]", "middle": ["August"], "last": "Stich", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Tanja", "middle": [], "last": "Schirmeister", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Fran\u00e5ois", "middle": [], "last": "Diederich", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [], "body_text": [{"text": "For some compounds, two conformers could be observed in the 1 H and 13 C NMR spectra as their interconversion was sufficiently slow on the NMR time scale. These cases are mentioned explicitly with the individual spectra. ( [11] N N N Cl ", "cite_spans": [{"start": 223, "end": 227, "text": "[11]", "ref_id": null}], "ref_spans": [], "section": "Table of Contents"}, {"text": "diffractometer with a graphite monochromator and Mo-K radiation = 0.71073 \u00c5. Crystal structures were solved by direct methods with SHELXS-97 and refined by fullmatrix least-squares analysis with SHELXL-97. [12] All non- ", "cite_spans": [{"start": 206, "end": 210, "text": "[12]", "ref_id": null}], "ref_spans": [], "section": "X-ray data was measured on a Bruker Nonius Kappa-CCD"}], "bib_entries": {"BIBREF7": {"ref_id": "b7", "title": "Evaluation of Enzyme Inhibitors in Drug Discovery", "authors": [{"first": "R", "middle": ["A"], "last": "Copeland", "suffix": ""}], "year": 2005, "venue": "", "volume": "46", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "X-ray crystal structure of 13 SI-X-ray crystal structure of 15 SI-Compound 1 bound to falcipain-2 SI-Compound 1 bound to rhodesain SI-Overlay of amino acids in the active sites of FP2, catB, and catL SI-6", "latex": null, "type": "figure"}, "FIGREF1": {"text": "first row and replaced by medium containing the highest dilution of compound; serial drug dilutions were prepared covering a range from 90-0.123 g/ml. The plates were incubated for another 72 h. 10 L of Alamar Blue (12.5 mg resazurin dissolved in 100 mL H 2 O) were then added to each well and incubation continued for a further 1-4 h. The plates were read with a Spectramax Gemini XS microplate fluorometer (Molecular Devices Cooperation, Sunnyvale, CA, USA) using an excitation wavelength of 530 nm and an emission wavelength of 590 nm. Data were analysed using the software Softmax Pro (Molecular Devices Cooperation,", "latex": null, "type": "figure"}, "FIGREF2": {"text": "mg, 0.73 mmol), 4 (200 mg, 0.73 mmol), and iPr 2 NEt (125 L, 0.73 mmol) in CH 2 Cl 2 (8 mL). Purification by FC (cyclohexane/EtOAc 20:1) gave 5 (242 g, 79%) as a yellow oil: R f = 0.70 (cyclohexane/", "latex": null, "type": "figure"}, "FIGREF3": {"text": "), 4.44 (tt, J = 11.7, 3.", "latex": null, "type": "figure"}, "FIGREF4": {"text": "(4-morpholinyl)-N-(4-propylcyclohexyl)-N-[3-(trifluoromethyl)benzyl]-1,3,5-triazin-2-amine (26) mmol), morpholine (17 L, 0.19 mmol), and iPr 2 NEt (33 L, 0.19 mmol) in CH 2 Cl 2 (3 mL). Purification by FC (cyclohexane/EtOAc 10:1) gave 26 (143 mg, 84%) as a white foam: R f = 0.45 (cyclohexane/EtOAc 4:1);", "latex": null, "type": "figure"}, "FIGREF5": {"text": "General procedure SI-D starting from 26 (60 mg, 0.12 mmol) and KCN (9 mg, 0.15 mmol) in DMSO (3 mL). Purification by FC (cyclohexane/EtOAc 20:1) gave 10 (28 mg, 47%) as a white foam: R f = 0.45 (cyclohexane/", "latex": null, "type": "figure"}, "FIGREF6": {"text": "procedure SI-B starting from cyanuric chloride (119 mg, 0.65 mmol), 27 (200 mg, 0.65 mmol), and iPr 2 NEt (111 L, 0.65 mmol) in CH 2 Cl 2 (8 mL). Purification by FC (cyclohexane/EtOAc 20:1) gave 28 (290 mg, 98%) as a colorless oil: R f = 0.67 (cyclohexane/", "latex": null, "type": "figure"}, "FIGREF7": {"text": "SI-D starting from 29 (39 mg, 0.07 mmol) and KCN (13 mg, 0.20 mmol) in DMSO (2 mL). Purification by FC (cyclohexane/EtOAc 20:1) gave 11 (30 mg, 86%) as a white foam: R f = 0.50 (cyclohexane/EtOAc 4:1);", "latex": null, "type": "figure"}, "FIGREF8": {"text": "gave 33 (663 mg, 61%) as a colorless oil: R NMR (100 MHz, CDCl 3 ; mixture of conformers); signals of major conformer: = 25.35, 25.62, 32.01, 32.24, 43.80, 55.88, 56.92, 66.69, 115.92 (d, 2 J(C,F) = 21.0 Hz), 124.02 (d, 3 J(C,F) = 3.7 Hz), 127.07 (d, 2 J(C,F) = 13.4 Hz),", "latex": null, "type": "figure"}, "FIGREF9": {"text": "mmol) and KCN (114 mg, 1.75 mmol) in DMSO (10 mL).", "latex": null, "type": "figure"}, "FIGREF10": {"text": "hydrogen atoms were refined anisotropically with exception of the minor part of disordered atoms in compound 13 and 15. Hydrogen positions of compound 13 were calculated based on stereochemical considerations and included in the structure factor calculation, for compound 7 and 15 Hatoms were refined isotropically. Supplementary crystallographic data has been deposited with the CCDC (deposition numbers: CCDC-793262 (13), CCDC-793263 (15) and CCDC-793264 (7)) and can be obtained free of charge from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK, www.ccdc.cam.ac.uk. 1052.8(2) \u00c5 3 , Z = 1, D calc = 1.24 g cm -3 , \u03bc = 0.08 mm -1 , crystal size 0.3 x 0.036 x 0.018 mm, colorless; 0.142 based on all reflections.", "latex": null, "type": "figure"}, "TABREF0": {"text": "run in duplicate and at least repeated once. Melarsoprol was used as positive control in every assay.", "latex": null, "type": "table"}, "TABREF18": {"text": "General procedure SI-E starting from cyanuric chloride mixture of conformers); signals of major conformer:=14.03, 25.48, 25.55, 25.75, 26.02, 30.42, 30.77, 37.54, 43.36, 43.83, 54.74, 66.63, 115.75, 151.60, 162.98, General procedure SI-E starting from cyanuric chloride (500 mg, 2.71 mmol), N-iso-propylcyclohexylamine (451 L, 2.71 mmol), morpholine (237 L, 2.71 mmol), and iPr 2 NEt (934 L, 5.42 mmol) in CH 2 Cl 2 (10 mL). Purification by FC (cyclohexane/EtOAc 10:1) gave 37 (666 mg, 72%) as a colorless foam: R f = 0.48 (cyclohexane/EtOAc 4:1); 1 H NMR (400 MHz, CDCl 3 ; mixture of conformers): = 1.08-1.42 (m, 55.05, 66.70, 163.97, 164.21, 168.72 ppm; IR (ATR): NMR (400 MHz, CDCl 3 ; mixture of conformers): = 1.08-1.41 (m, 10 H), 1.61-1.82 (m, 6 H), 2.16 (br. s, 1 H), 3.74-3.78 (m, 8 H), 4.04-4.63 ppm (br. m, 1 H); 13 C NMR (100 MHz, CDCl 3 ; mixture of conformers); signals of major conformer: = 19.98, 20.35, 25.44, 25.77, 26.03, 26.28, 29.71, 30.31, 43.95, 46.53, 55.31, 66.69, 115.81, 151.36, 163.10, 163.18 ppm; signals of minor conformer: = 46.71, 55.05, 151.27, 163.25 ppm; IR (ATR): \u02dc = 2928, 2855, 1801, 1556, 1480, 1363, 1330, 1304, 1238, 1182, 1147, 1115, 1069, 1045, 1018, 1003, 991, 959, 894, 868, 834, 804 cm -1 ; HRMS-ESI: m/z calcd for C 17 H 27 N 6 O [M + H] + : 331.2241, found: 331.2233 (100%).", "latex": null, "type": "table"}}, "back_matter": []}